Jubilant Pharmova approves ₹800 crore NCD issue
By United One News · AI-generated summary of 1 outlet's reporting
Published
AI-generated summary of the coverage listed below:
- Jubilant Pharmova’s board cleared a ₹800 crore non‑convertible debenture issue to be raised via private placement.
- The interest rate will be set through a bidding process.
Covered by 1 outlet across the spectrum: 0% left, 100% center, 0% right.
How each side framed it
Jubilant Pharmova approves ₹800 crore NCD issue through private placement
Timeline
First reported by The Hindu BusinessLine on ; 1 article from 1 outlet so far.
Who is covering this story
- Center (1): The Hindu BusinessLine